These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18066014)

  • 21. Recent patent applications in tissue engineering.
    Nat Biotechnol; 2006 Sep; 24(9):1095. PubMed ID: 16964216
    [No Abstract]   [Full Text] [Related]  

  • 22. Biotech holds its own in Q2.
    Lawrence S
    Nat Biotechnol; 2004 Aug; 22(8):938. PubMed ID: 15286634
    [No Abstract]   [Full Text] [Related]  

  • 23. Biotech holds steady in Q4.
    Mitchell P
    Nat Biotechnol; 2004 Feb; 22(2):135-6. PubMed ID: 14755275
    [No Abstract]   [Full Text] [Related]  

  • 24. European Commission rethinks biotech patents.
    Mitchell P
    Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
    [No Abstract]   [Full Text] [Related]  

  • 25. Biotechnology and the new property regime in human bodies and body parts.
    Nwabueze RN
    Loyola Los Angel Int Comp Law J; 2002 Jan; 24(1):19-64. PubMed ID: 12769112
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of gene patenting on R&D and commerce.
    Stott M; Valentine J
    Nat Biotechnol; 2003 Jul; 21(7):729-31; author reply 731. PubMed ID: 12833081
    [No Abstract]   [Full Text] [Related]  

  • 27. University biotech patenting 2013.
    Huggett B; Paisner K
    Nat Biotechnol; 2014 Jun; 32(6):512. PubMed ID: 24911487
    [No Abstract]   [Full Text] [Related]  

  • 28. Lack of private financing hobbles emerging biotech regions.
    Jia H; Jayarama KS; Astvatsaturyan M
    Nat Biotechnol; 2006 Jan; 24(1):7-9. PubMed ID: 16404378
    [No Abstract]   [Full Text] [Related]  

  • 29. EPO neem patent revocation revives biopiracy debate.
    Sheridan C
    Nat Biotechnol; 2005 May; 23(5):511-2. PubMed ID: 15877054
    [No Abstract]   [Full Text] [Related]  

  • 30. Trends in biotech literature 2005.
    Lawrence S
    Nat Biotechnol; 2006 Apr; 24(4):380. PubMed ID: 16601711
    [No Abstract]   [Full Text] [Related]  

  • 31. Research biotech patenting 2014.
    Huggett B; Paisner K
    Nat Biotechnol; 2015 Jul; 33(7):684. PubMed ID: 26154000
    [No Abstract]   [Full Text] [Related]  

  • 32. Mixed results in Q1.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):518. PubMed ID: 15877059
    [No Abstract]   [Full Text] [Related]  

  • 33. Patent holdings of US biotherapeutic companies in major markets.
    Sebastian TE; Yerram CB; Saberwal G
    Drug Discov Today; 2009 May; 14(9-10):442-5. PubMed ID: 19429502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent patent applications in protein purification.
    Nat Biotechnol; 2006 Oct; 24(10):1222. PubMed ID: 17033656
    [No Abstract]   [Full Text] [Related]  

  • 35. Accord could lift block on European biotech patents.
    Abbott A
    Nature; 1997 Jun; 387(6636):835. PubMed ID: 9202106
    [No Abstract]   [Full Text] [Related]  

  • 36. China steps up US biotech intellectual property land grab.
    Ratner M
    Nat Biotechnol; 2008 Feb; 26(2):141-2. PubMed ID: 18259157
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent patent applications in systems biology.
    Nat Biotechnol; 2005 Aug; 23(8):939. PubMed ID: 16082360
    [No Abstract]   [Full Text] [Related]  

  • 38. Profit and the patent on life.
    Attali J
    New Perspect Q; 1994; 11(1):12-5. PubMed ID: 15739292
    [No Abstract]   [Full Text] [Related]  

  • 39. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

  • 40. Lords panel backs ethical barriers to biotech patents.
    Nature; 1994 Mar; 368(6469):278. PubMed ID: 8127355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.